Omicron Vaccine’ may be available by early 2022: Moderna

Moderna

Moderna

The Omicron variant, discovered in Southern Africa, has a greater number of mutations and has spread rapidly. Several countries have closed their borders and renewed Covid-19 restrictions as a result of the variant. But, don’t worry as Moderna informs, ‘Omicron Vaccine’ may be available by early 2022. 

Paul Burton, Moderna’s chief medical officer, stated during an appearance on a BBC show. “We should know about the ability of the current vaccine to provide protection in the next couple of weeks.” “If we have to make a brand new vaccine, I think that’s going to be early 2022 before that’s really going to be available in large quantities,” Burton adds. His remarks come after the vaccine manufacturer mobilized hundreds of its employees last Thursday after the Omicron variant made international headlines. On Sunday, Burton stated that current vaccines should protect against the variant and that all unvaccinated people should get the shot.

If we have to make a brand new vaccine, I think that’s going to be early 2022

“If people are on the fence, and you haven’t been vaccinated, get vaccinated,” he says. This is a dangerous-looking virus. But I think we have many tools in our armamentarium now to fight it,” Moderna’s top executive informs during his interaction with the BBC. The Omicron variant, discovered in southern Africa, has a greater number of mutations and has spread rapidly. Several countries have closed their borders and renewed Covid-19 restrictions as a result of the variant.

South African health experts, including the doctor who first raised the alarm about Omicron. They have stated that the symptoms associated with the variant. It has been mild up to this point. However, the World Health Organization (WHO) has advised caution. Stating that the initial cases of the variant symptoms are rare and that younger patients have milder symptoms. “There is currently no information to suggest that symptoms associated with omicron. These are different from those from other variants,” the WHO adds.

Exit mobile version